In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leveraging Assay Platforms to Create Category-Killer Diagnostic Tests

Executive Summary

The availability of novel assay platforms represents a tipping point for diagnostics' adoption in the markets for translational medicine, esoteric testing, and high-complexity labs. Platform companies may be accustomed to defining their business strategies in terms of maximizing instrument placements but this may not be the optimal path to commercial success for a novel diagnostic test. They need to develop "category-killer" tests--those that combine platform and diagnostic content to offer a compelling clinical value proposition.
Advertisement

Related Content

Delivering Cancer Diagnostics Tools
Nanostring Unveils Its Molecular Diagnostics Strategy
Taking Stock Of Qiagen
Noninvasive Prenatal Diagnostics: How Much Closer to Reality?
Noninvasive Prenatal Diagnostics: How Much Closer to Reality?
How to Earn the Economic Payback Diagnostics Companies Deserve
Can Nanotech Be a Game-Changer for In Vitro Diagnostics?
Can Nanotech Be a Game-Changer for In Vitro Diagnostics?
Wake-up Calls in IVD
Wake-up Calls in IVD

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003235

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel